BioCentury
ARTICLE | Company News

Karo Bio, Pfizer deal

January 2, 2012 8:00 AM UTC

Karo partnered with Pfizer to discover and develop small molecule RAR-related orphan receptor C ( RORC; RORgamma; RORgammaT) modulators to treat autoimmune diseases. Pfizer gains exclusive rights to...